[1]
“Molecular Docking Studies of Schiff Bases with Azetidinone Against Dihydrofolate Reductase Enzyme as Potential Anti-cancer Agents”, AJP, vol. 18, no. 02, Jun. 2024, doi: 10.22377/ajp.v18i02.5480.